Squarepoint’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $554K | Buy |
138,462
+37,430
| +37% | +$150K | ﹤0.01% | 1855 |
|
|
2025
Q1 | $321K | Buy |
101,032
+2,888
| +3% | +$9.18K | ﹤0.01% | 2160 |
|
|
2024
Q4 | $525K | Buy |
98,144
+86,064
| +712% | +$460K | ﹤0.01% | 1915 |
|
|
2024
Q3 | $63.8K | Buy |
+12,080
| New | +$63.8K | ﹤0.01% | 2408 |
|
|
2023
Q3 | – | Sell |
-17,082
| Closed | -$39.1K | – | 2517 |
|
|
2023
Q2 | $39.1K | Buy |
+17,082
| New | +$39.1K | ﹤0.01% | 2307 |
|
|
2022
Q1 | – | Sell |
-13,118
| Closed | -$32K | – | 2333 |
|
|
2021
Q4 | $32K | Sell |
13,118
-6,836
| -34% | -$16.7K | ﹤0.01% | 2456 |
|
|
2021
Q3 | $97K | Buy |
+19,954
| New | +$97K | ﹤0.01% | 2011 |
|
|
2020
Q3 | – | Sell |
-26,418
| Closed | -$72K | – | 2376 |
|
|
2020
Q2 | $72K | Buy |
26,418
+1,982
| +8% | +$5.4K | ﹤0.01% | 1985 |
|
|
2020
Q1 | $52K | Buy |
+24,436
| New | +$52K | ﹤0.01% | 1708 |
|
|
2019
Q2 | – | Sell |
-45,785
| Closed | -$184K | – | 2336 |
|
|
2019
Q1 | $184K | Sell |
45,785
-27,669
| -38% | -$111K | ﹤0.01% | 1901 |
|
|
2018
Q4 | $270K | Buy |
73,454
+22,630
| +45% | +$83.2K | ﹤0.01% | 1536 |
|
|
2018
Q3 | $436K | Buy |
50,824
+35,771
| +238% | +$307K | 0.01% | 1361 |
|
|
2018
Q2 | $165K | Buy |
15,053
+1,675
| +13% | +$18.4K | ﹤0.01% | 1572 |
|
|
2018
Q1 | $154K | Buy |
+13,378
| New | +$154K | ﹤0.01% | 1524 |
|